SMO and chronic myelogenous leukemia, BCR-ABL1 positive: Similarly, HH signaling was found to be essential for maintenance of CSCs in chronic myelogenous leukemia (CML), as SMO−/− cells displayed reduced tumorigenicity in CML mouse models [493].